Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management

    July 2016 in “ Current pharmaceutical design ”
    Poli Mara Spritzer, Carolina Rocha Barone, Fabiana Bazanella de Oliveira
    TLDR The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.
    The study reviewed the pathophysiology and management of hirsutism in women with polycystic ovary syndrome (PCOS), noting that 70-80% of women with PCOS experience hirsutism compared to 4-11% in the general population. Hirsutism in PCOS was linked to ovarian-derived androgen excess and individual sensitivity to androgens. Treatment options included combined oral contraceptives (OCPs) to suppress androgen excess, with metformin and lifestyle changes as alternatives for those with contraindications to OCPs. The severity of hirsutism, assessed by the modified Ferriman-Gallwey score, and the distress it caused to patients guided treatment choices, which needed to be maintained for 6-12 months. Mild cases were treated with non-pharmacological methods and OCPs, while moderate to severe cases required antiandrogens and OCPs or a safe contraceptive method if OCPs were not suitable. Individualized management considering metabolic comorbidities and menstrual disturbances was emphasized for effective treatment.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 25 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community AA and Hirsutism but T levels are normal

      in Female  8 upvotes 3 years ago
      27-year-old female experiences aggressive hair thinning and hirsutism despite normal testosterone levels. Spironolactone and 2% minoxidil were ineffective; high DHEA sulfate levels may be the cause.

      community Finasteride 5mg & Spironolactone 100mg

      in Female  2 upvotes 3 weeks ago
      A 20-year-old female is using finasteride 5mg and spironolactone 100mg for severe hirsutism and is experiencing minor side effects like water weight loss and irregular periods. She is concerned about potential future side effects and hair regrowth on her scalp.

      community No, Finasteride as a treatment for MPB was not an "accident"

      in Research/Science  105 upvotes 3 years ago
      Finasteride was intentionally developed to treat BPH and later approved for male pattern baldness (MPB) due to its 5AR inhibition effects. The delay in MPB approval was due to concerns about off-label use for female hirsutism and the prioritization of treating a more debilitating condition.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

    Related Research

    3 / 3 results